Part 2 of a 2 part series. For years, the issue of manufacturing capacity and drug speed to market has plagued the manufacture of biologics and vaccines, until now. In 2018, iCON, a completely integrated turnkey facility platform, solved the solution to a long-standing industry problem. Moreover, iCON helped pharmaceutical and biopharmaceutical companies improve delivery capacity by standardizing the infrastructure for a flexible and readily available drug manufacturing facility across the globe.

But how? In this virtual roundtable, the creators of iCON, G-CON Manufacturing and IPS-Integrated Project Services, along with collaborating partner, Asgard Cleanroom Solutions, hold an open discussion, answering your frequently asked questions about the industry’s first turnkey modular facility platform.